Drugs to Watch report: 15 blockbusters for 2023

Clarivate study highlights treatments with blockbuster potential | IV, Parkinson’s disease, Crohn’s disease, alopecia, multiple myeloma and breast cancer make the list | Nine blockbusters from China also predicted.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Chugai settles cancer drug patent dispute with US firm

10 August 2022 Parties to withdraw lawsuit over lung cancer drug | ANDA generic would have displaced sales of patented version in Delaware, said plaintiff.

Generics

Repurposed drugs: protections and incentives

13 April 2021 Repurposing drugs has very clear benefits. It gives companies the opportunity to develop entirely new uses for existing drugs that they don’t have patent protection, and may allow innovator companies to protect a molecule or formulation even after initial patent protection has expired.

More on this story

Americas

Chugai settles cancer drug patent dispute with US firm

10 August 2022 Parties to withdraw lawsuit over lung cancer drug | ANDA generic would have displaced sales of patented version in Delaware, said plaintiff.

Generics

Repurposed drugs: protections and incentives

More on this story

Americas

Chugai settles cancer drug patent dispute with US firm

10 August 2022 Parties to withdraw lawsuit over lung cancer drug | ANDA generic would have displaced sales of patented version in Delaware, said plaintiff.

Generics

Repurposed drugs: protections and incentives